suPARnostic
Amager Hospital, Denmark, starts measuring suPAR on all Acute Clinical Patients
Amager Hospital, Denmark has entered an agreement with ViroGates for the use of suPARnostic® TurbiLatex in clinical routine practice for the triage and severity assessment of all acute clinical patients in the Emergency Room.
Meet us at DASEM 2019 in Middelfart, Denmark
Meet us at DASEM 2019 - Årsmøde Dansk Selskab for Akutmedicin / Danish Society for Emergency Medicine on April 26-27 in Middelfart, Denmark.
suPARnostic® TurbiLatex now CE-IVD approved for Roche Cobas c500/c700 series
ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c500 and c700 series has been completed.
suPARnostic® TurbiLatex now CE-IVD approved for Roche Cobas c502 module
ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c502 has been completed.
